G-CSF Biosimilars Market, Global Outlook and Forecast 2022-2028
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
This report contains market size and forecasts of G-CSF Biosimilars in global, including the following market information:
Global G-CSF Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global G-CSF Biosimilars Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five G-CSF Biosimilars companies in 2021 (%)
The global G-CSF Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human Growth Hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of G-CSF Biosimilars include Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the G-CSF Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global G-CSF Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global G-CSF Biosimilars Market Segment Percentages, by Type, 2021 (%)
Global G-CSF Biosimilars Market Segment Percentages, by Application, 2021 (%)
Global G-CSF Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies G-CSF Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies G-CSF Biosimilars revenues share in global market, 2021 (%)
Key companies G-CSF Biosimilars sales in global market, 2017-2022 (Estimated), (K Units)
Key companies G-CSF Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of G-CSF Biosimilars in global, including the following market information:
Global G-CSF Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global G-CSF Biosimilars Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five G-CSF Biosimilars companies in 2021 (%)
The global G-CSF Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human Growth Hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of G-CSF Biosimilars include Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the G-CSF Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global G-CSF Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global G-CSF Biosimilars Market Segment Percentages, by Type, 2021 (%)
- Human Growth Hormone
- Erythropoietin
- Monoclonal Antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
Global G-CSF Biosimilars Market Segment Percentages, by Application, 2021 (%)
- Blood Disorders
- Oncology Diseases
- Chronic And Autoimmune Diseases
- Growth Hormone Deficiencies
Global G-CSF Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies G-CSF Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies G-CSF Biosimilars revenues share in global market, 2021 (%)
Key companies G-CSF Biosimilars sales in global market, 2017-2022 (Estimated), (K Units)
Key companies G-CSF Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Roche
- Merck & Co.
- Sanofi
- Johnson & Johnson
- Gilead Science
- GlaxoSmithKline
- AbbVie
- Amgen
- AstraZeneca
- Bayer
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 G-CSF Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global G-CSF Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL G-CSF BIOSIMILARS OVERALL MARKET SIZE
2.1 Global G-CSF Biosimilars Market Size: 2021 VS 2028
2.2 Global G-CSF Biosimilars Revenue, Prospects & Forecasts: 2017-2028
2.3 Global G-CSF Biosimilars Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top G-CSF Biosimilars Players in Global Market
3.2 Top Global G-CSF Biosimilars Companies Ranked by Revenue
3.3 Global G-CSF Biosimilars Revenue by Companies
3.4 Global G-CSF Biosimilars Sales by Companies
3.5 Global G-CSF Biosimilars Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 G-CSF Biosimilars Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers G-CSF Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 G-CSF Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 G-CSF Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 G-CSF Biosimilars Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global G-CSF Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Human Growth Hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal Antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.2 By Type - Global G-CSF Biosimilars Revenue & Forecasts
4.2.1 By Type - Global G-CSF Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global G-CSF Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
4.3 By Type - Global G-CSF Biosimilars Sales & Forecasts
4.3.1 By Type - Global G-CSF Biosimilars Sales, 2017-2022
4.3.2 By Type - Global G-CSF Biosimilars Sales, 2023-2028
4.3.3 By Type - Global G-CSF Biosimilars Sales Market Share, 2017-2028
4.4 By Type - Global G-CSF Biosimilars Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global G-CSF Biosimilars Market Size, 2021 & 2028
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic And Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.2 By Application - Global G-CSF Biosimilars Revenue & Forecasts
5.2.1 By Application - Global G-CSF Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global G-CSF Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
5.3 By Application - Global G-CSF Biosimilars Sales & Forecasts
5.3.1 By Application - Global G-CSF Biosimilars Sales, 2017-2022
5.3.2 By Application - Global G-CSF Biosimilars Sales, 2023-2028
5.3.3 By Application - Global G-CSF Biosimilars Sales Market Share, 2017-2028
5.4 By Application - Global G-CSF Biosimilars Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global G-CSF Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global G-CSF Biosimilars Revenue & Forecasts
6.2.1 By Region - Global G-CSF Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global G-CSF Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
6.3 By Region - Global G-CSF Biosimilars Sales & Forecasts
6.3.1 By Region - Global G-CSF Biosimilars Sales, 2017-2022
6.3.2 By Region - Global G-CSF Biosimilars Sales, 2023-2028
6.3.3 By Region - Global G-CSF Biosimilars Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America G-CSF Biosimilars Revenue, 2017-2028
6.4.2 By Country - North America G-CSF Biosimilars Sales, 2017-2028
6.4.3 US G-CSF Biosimilars Market Size, 2017-2028
6.4.4 Canada G-CSF Biosimilars Market Size, 2017-2028
6.4.5 Mexico G-CSF Biosimilars Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe G-CSF Biosimilars Revenue, 2017-2028
6.5.2 By Country - Europe G-CSF Biosimilars Sales, 2017-2028
6.5.3 Germany G-CSF Biosimilars Market Size, 2017-2028
6.5.4 France G-CSF Biosimilars Market Size, 2017-2028
6.5.5 U.K. G-CSF Biosimilars Market Size, 2017-2028
6.5.6 Italy G-CSF Biosimilars Market Size, 2017-2028
6.5.7 Russia G-CSF Biosimilars Market Size, 2017-2028
6.5.8 Nordic Countries G-CSF Biosimilars Market Size, 2017-2028
6.5.9 Benelux G-CSF Biosimilars Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia G-CSF Biosimilars Revenue, 2017-2028
6.6.2 By Region - Asia G-CSF Biosimilars Sales, 2017-2028
6.6.3 China G-CSF Biosimilars Market Size, 2017-2028
6.6.4 Japan G-CSF Biosimilars Market Size, 2017-2028
6.6.5 South Korea G-CSF Biosimilars Market Size, 2017-2028
6.6.6 Southeast Asia G-CSF Biosimilars Market Size, 2017-2028
6.6.7 India G-CSF Biosimilars Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America G-CSF Biosimilars Revenue, 2017-2028
6.7.2 By Country - South America G-CSF Biosimilars Sales, 2017-2028
6.7.3 Brazil G-CSF Biosimilars Market Size, 2017-2028
6.7.4 Argentina G-CSF Biosimilars Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa G-CSF Biosimilars Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa G-CSF Biosimilars Sales, 2017-2028
6.8.3 Turkey G-CSF Biosimilars Market Size, 2017-2028
6.8.4 Israel G-CSF Biosimilars Market Size, 2017-2028
6.8.5 Saudi Arabia G-CSF Biosimilars Market Size, 2017-2028
6.8.6 UAE G-CSF Biosimilars Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer G-CSF Biosimilars Major Product Offerings
7.1.4 Pfizer G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis G-CSF Biosimilars Major Product Offerings
7.2.4 Novartis G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche G-CSF Biosimilars Major Product Offerings
7.3.4 Roche G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Merck & Co.
7.4.1 Merck & Co. Corporate Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. G-CSF Biosimilars Major Product Offerings
7.4.4 Merck & Co. G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.4.5 Merck & Co. Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi G-CSF Biosimilars Major Product Offerings
7.5.4 Sanofi G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson G-CSF Biosimilars Major Product Offerings
7.6.4 Johnson & Johnson G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Gilead Science
7.7.1 Gilead Science Corporate Summary
7.7.2 Gilead Science Business Overview
7.7.3 Gilead Science G-CSF Biosimilars Major Product Offerings
7.7.4 Gilead Science G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.7.5 Gilead Science Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline G-CSF Biosimilars Major Product Offerings
7.8.4 GlaxoSmithKline G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie G-CSF Biosimilars Major Product Offerings
7.9.4 AbbVie G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.9.5 AbbVie Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen G-CSF Biosimilars Major Product Offerings
7.10.4 Amgen G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.10.5 Amgen Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca G-CSF Biosimilars Business Overview
7.11.3 AstraZeneca G-CSF Biosimilars Major Product Offerings
7.11.4 AstraZeneca G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer G-CSF Biosimilars Business Overview
7.12.3 Bayer G-CSF Biosimilars Major Product Offerings
7.12.4 Bayer G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.12.5 Bayer Key News
8 GLOBAL G-CSF BIOSIMILARS PRODUCTION CAPACITY, ANALYSIS
8.1 Global G-CSF Biosimilars Production Capacity, 2017-2028
8.2 G-CSF Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global G-CSF Biosimilars Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 G-CSF BIOSIMILARS SUPPLY CHAIN ANALYSIS
10.1 G-CSF Biosimilars Industry Value Chain
10.2 G-CSF Biosimilars Upstream Market
10.3 G-CSF Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 G-CSF Biosimilars Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 G-CSF Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global G-CSF Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL G-CSF BIOSIMILARS OVERALL MARKET SIZE
2.1 Global G-CSF Biosimilars Market Size: 2021 VS 2028
2.2 Global G-CSF Biosimilars Revenue, Prospects & Forecasts: 2017-2028
2.3 Global G-CSF Biosimilars Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top G-CSF Biosimilars Players in Global Market
3.2 Top Global G-CSF Biosimilars Companies Ranked by Revenue
3.3 Global G-CSF Biosimilars Revenue by Companies
3.4 Global G-CSF Biosimilars Sales by Companies
3.5 Global G-CSF Biosimilars Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 G-CSF Biosimilars Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers G-CSF Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 G-CSF Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 G-CSF Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 G-CSF Biosimilars Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global G-CSF Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Human Growth Hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal Antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.2 By Type - Global G-CSF Biosimilars Revenue & Forecasts
4.2.1 By Type - Global G-CSF Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global G-CSF Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
4.3 By Type - Global G-CSF Biosimilars Sales & Forecasts
4.3.1 By Type - Global G-CSF Biosimilars Sales, 2017-2022
4.3.2 By Type - Global G-CSF Biosimilars Sales, 2023-2028
4.3.3 By Type - Global G-CSF Biosimilars Sales Market Share, 2017-2028
4.4 By Type - Global G-CSF Biosimilars Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global G-CSF Biosimilars Market Size, 2021 & 2028
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic And Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.2 By Application - Global G-CSF Biosimilars Revenue & Forecasts
5.2.1 By Application - Global G-CSF Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global G-CSF Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
5.3 By Application - Global G-CSF Biosimilars Sales & Forecasts
5.3.1 By Application - Global G-CSF Biosimilars Sales, 2017-2022
5.3.2 By Application - Global G-CSF Biosimilars Sales, 2023-2028
5.3.3 By Application - Global G-CSF Biosimilars Sales Market Share, 2017-2028
5.4 By Application - Global G-CSF Biosimilars Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global G-CSF Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global G-CSF Biosimilars Revenue & Forecasts
6.2.1 By Region - Global G-CSF Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global G-CSF Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
6.3 By Region - Global G-CSF Biosimilars Sales & Forecasts
6.3.1 By Region - Global G-CSF Biosimilars Sales, 2017-2022
6.3.2 By Region - Global G-CSF Biosimilars Sales, 2023-2028
6.3.3 By Region - Global G-CSF Biosimilars Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America G-CSF Biosimilars Revenue, 2017-2028
6.4.2 By Country - North America G-CSF Biosimilars Sales, 2017-2028
6.4.3 US G-CSF Biosimilars Market Size, 2017-2028
6.4.4 Canada G-CSF Biosimilars Market Size, 2017-2028
6.4.5 Mexico G-CSF Biosimilars Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe G-CSF Biosimilars Revenue, 2017-2028
6.5.2 By Country - Europe G-CSF Biosimilars Sales, 2017-2028
6.5.3 Germany G-CSF Biosimilars Market Size, 2017-2028
6.5.4 France G-CSF Biosimilars Market Size, 2017-2028
6.5.5 U.K. G-CSF Biosimilars Market Size, 2017-2028
6.5.6 Italy G-CSF Biosimilars Market Size, 2017-2028
6.5.7 Russia G-CSF Biosimilars Market Size, 2017-2028
6.5.8 Nordic Countries G-CSF Biosimilars Market Size, 2017-2028
6.5.9 Benelux G-CSF Biosimilars Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia G-CSF Biosimilars Revenue, 2017-2028
6.6.2 By Region - Asia G-CSF Biosimilars Sales, 2017-2028
6.6.3 China G-CSF Biosimilars Market Size, 2017-2028
6.6.4 Japan G-CSF Biosimilars Market Size, 2017-2028
6.6.5 South Korea G-CSF Biosimilars Market Size, 2017-2028
6.6.6 Southeast Asia G-CSF Biosimilars Market Size, 2017-2028
6.6.7 India G-CSF Biosimilars Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America G-CSF Biosimilars Revenue, 2017-2028
6.7.2 By Country - South America G-CSF Biosimilars Sales, 2017-2028
6.7.3 Brazil G-CSF Biosimilars Market Size, 2017-2028
6.7.4 Argentina G-CSF Biosimilars Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa G-CSF Biosimilars Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa G-CSF Biosimilars Sales, 2017-2028
6.8.3 Turkey G-CSF Biosimilars Market Size, 2017-2028
6.8.4 Israel G-CSF Biosimilars Market Size, 2017-2028
6.8.5 Saudi Arabia G-CSF Biosimilars Market Size, 2017-2028
6.8.6 UAE G-CSF Biosimilars Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer G-CSF Biosimilars Major Product Offerings
7.1.4 Pfizer G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis G-CSF Biosimilars Major Product Offerings
7.2.4 Novartis G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche G-CSF Biosimilars Major Product Offerings
7.3.4 Roche G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Merck & Co.
7.4.1 Merck & Co. Corporate Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. G-CSF Biosimilars Major Product Offerings
7.4.4 Merck & Co. G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.4.5 Merck & Co. Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi G-CSF Biosimilars Major Product Offerings
7.5.4 Sanofi G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson G-CSF Biosimilars Major Product Offerings
7.6.4 Johnson & Johnson G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Gilead Science
7.7.1 Gilead Science Corporate Summary
7.7.2 Gilead Science Business Overview
7.7.3 Gilead Science G-CSF Biosimilars Major Product Offerings
7.7.4 Gilead Science G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.7.5 Gilead Science Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline G-CSF Biosimilars Major Product Offerings
7.8.4 GlaxoSmithKline G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie G-CSF Biosimilars Major Product Offerings
7.9.4 AbbVie G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.9.5 AbbVie Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen G-CSF Biosimilars Major Product Offerings
7.10.4 Amgen G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.10.5 Amgen Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca G-CSF Biosimilars Business Overview
7.11.3 AstraZeneca G-CSF Biosimilars Major Product Offerings
7.11.4 AstraZeneca G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer G-CSF Biosimilars Business Overview
7.12.3 Bayer G-CSF Biosimilars Major Product Offerings
7.12.4 Bayer G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.12.5 Bayer Key News
8 GLOBAL G-CSF BIOSIMILARS PRODUCTION CAPACITY, ANALYSIS
8.1 Global G-CSF Biosimilars Production Capacity, 2017-2028
8.2 G-CSF Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global G-CSF Biosimilars Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 G-CSF BIOSIMILARS SUPPLY CHAIN ANALYSIS
10.1 G-CSF Biosimilars Industry Value Chain
10.2 G-CSF Biosimilars Upstream Market
10.3 G-CSF Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 G-CSF Biosimilars Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of G-CSF Biosimilars in Global Market
Table 2. Top G-CSF Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 3. Global G-CSF Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global G-CSF Biosimilars Revenue Share by Companies, 2017-2022
Table 5. Global G-CSF Biosimilars Sales by Companies, (K Units), 2017-2022
Table 6. Global G-CSF Biosimilars Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers G-CSF Biosimilars Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers G-CSF Biosimilars Product Type
Table 9. List of Global Tier 1 G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global G-CSF Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global G-CSF Biosimilars Sales (K Units), 2017-2022
Table 15. By Type - Global G-CSF Biosimilars Sales (K Units), 2023-2028
Table 16. By Application – Global G-CSF Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global G-CSF Biosimilars Sales (K Units), 2017-2022
Table 20. By Application - Global G-CSF Biosimilars Sales (K Units), 2023-2028
Table 21. By Region – Global G-CSF Biosimilars Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global G-CSF Biosimilars Sales (K Units), 2017-2022
Table 25. By Region - Global G-CSF Biosimilars Sales (K Units), 2023-2028
Table 26. By Country - North America G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 29. By Country - North America G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 30. By Country - Europe G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 33. By Country - Europe G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 34. By Region - Asia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 37. By Region - Asia G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 38. By Country - South America G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 41. By Country - South America G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer G-CSF Biosimilars Product Offerings
Table 48. Pfizer G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis G-CSF Biosimilars Product Offerings
Table 51. Novartis G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche G-CSF Biosimilars Product Offerings
Table 54. Roche G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Merck & Co. Corporate Summary
Table 56. Merck & Co. G-CSF Biosimilars Product Offerings
Table 57. Merck & Co. G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi G-CSF Biosimilars Product Offerings
Table 60. Sanofi G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson G-CSF Biosimilars Product Offerings
Table 63. Johnson & Johnson G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Gilead Science Corporate Summary
Table 65. Gilead Science G-CSF Biosimilars Product Offerings
Table 66. Gilead Science G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. GlaxoSmithKline Corporate Summary
Table 68. GlaxoSmithKline G-CSF Biosimilars Product Offerings
Table 69. GlaxoSmithKline G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. AbbVie Corporate Summary
Table 71. AbbVie G-CSF Biosimilars Product Offerings
Table 72. AbbVie G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Amgen Corporate Summary
Table 74. Amgen G-CSF Biosimilars Product Offerings
Table 75. Amgen G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca G-CSF Biosimilars Product Offerings
Table 78. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Bayer Corporate Summary
Table 80. Bayer G-CSF Biosimilars Product Offerings
Table 81. Bayer G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. G-CSF Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global G-CSF Biosimilars Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global G-CSF Biosimilars Production by Region, 2017-2022 (K Units)
Table 85. Global G-CSF Biosimilars Production by Region, 2023-2028 (K Units)
Table 86. G-CSF Biosimilars Market Opportunities & Trends in Global Market
Table 87. G-CSF Biosimilars Market Drivers in Global Market
Table 88. G-CSF Biosimilars Market Restraints in Global Market
Table 89. G-CSF Biosimilars Raw Materials
Table 90. G-CSF Biosimilars Raw Materials Suppliers in Global Market
Table 91. Typical G-CSF Biosimilars Downstream
Table 92. G-CSF Biosimilars Downstream Clients in Global Market
Table 93. G-CSF Biosimilars Distributors and Sales Agents in Global Market
Table 1. Key Players of G-CSF Biosimilars in Global Market
Table 2. Top G-CSF Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 3. Global G-CSF Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global G-CSF Biosimilars Revenue Share by Companies, 2017-2022
Table 5. Global G-CSF Biosimilars Sales by Companies, (K Units), 2017-2022
Table 6. Global G-CSF Biosimilars Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers G-CSF Biosimilars Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers G-CSF Biosimilars Product Type
Table 9. List of Global Tier 1 G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global G-CSF Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global G-CSF Biosimilars Sales (K Units), 2017-2022
Table 15. By Type - Global G-CSF Biosimilars Sales (K Units), 2023-2028
Table 16. By Application – Global G-CSF Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global G-CSF Biosimilars Sales (K Units), 2017-2022
Table 20. By Application - Global G-CSF Biosimilars Sales (K Units), 2023-2028
Table 21. By Region – Global G-CSF Biosimilars Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global G-CSF Biosimilars Sales (K Units), 2017-2022
Table 25. By Region - Global G-CSF Biosimilars Sales (K Units), 2023-2028
Table 26. By Country - North America G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 29. By Country - North America G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 30. By Country - Europe G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 33. By Country - Europe G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 34. By Region - Asia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 37. By Region - Asia G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 38. By Country - South America G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 41. By Country - South America G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer G-CSF Biosimilars Product Offerings
Table 48. Pfizer G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis G-CSF Biosimilars Product Offerings
Table 51. Novartis G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche G-CSF Biosimilars Product Offerings
Table 54. Roche G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Merck & Co. Corporate Summary
Table 56. Merck & Co. G-CSF Biosimilars Product Offerings
Table 57. Merck & Co. G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi G-CSF Biosimilars Product Offerings
Table 60. Sanofi G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson G-CSF Biosimilars Product Offerings
Table 63. Johnson & Johnson G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Gilead Science Corporate Summary
Table 65. Gilead Science G-CSF Biosimilars Product Offerings
Table 66. Gilead Science G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. GlaxoSmithKline Corporate Summary
Table 68. GlaxoSmithKline G-CSF Biosimilars Product Offerings
Table 69. GlaxoSmithKline G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. AbbVie Corporate Summary
Table 71. AbbVie G-CSF Biosimilars Product Offerings
Table 72. AbbVie G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Amgen Corporate Summary
Table 74. Amgen G-CSF Biosimilars Product Offerings
Table 75. Amgen G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca G-CSF Biosimilars Product Offerings
Table 78. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Bayer Corporate Summary
Table 80. Bayer G-CSF Biosimilars Product Offerings
Table 81. Bayer G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. G-CSF Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global G-CSF Biosimilars Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global G-CSF Biosimilars Production by Region, 2017-2022 (K Units)
Table 85. Global G-CSF Biosimilars Production by Region, 2023-2028 (K Units)
Table 86. G-CSF Biosimilars Market Opportunities & Trends in Global Market
Table 87. G-CSF Biosimilars Market Drivers in Global Market
Table 88. G-CSF Biosimilars Market Restraints in Global Market
Table 89. G-CSF Biosimilars Raw Materials
Table 90. G-CSF Biosimilars Raw Materials Suppliers in Global Market
Table 91. Typical G-CSF Biosimilars Downstream
Table 92. G-CSF Biosimilars Downstream Clients in Global Market
Table 93. G-CSF Biosimilars Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. G-CSF Biosimilars Segment by Type
Figure 2. G-CSF Biosimilars Segment by Application
Figure 3. Global G-CSF Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global G-CSF Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global G-CSF Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. G-CSF Biosimilars Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by G-CSF Biosimilars Revenue in 2021
Figure 9. By Type - Global G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 10. By Type - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Type - Global G-CSF Biosimilars Price (USD/Unit), 2017-2028
Figure 12. By Application - Global G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 13. By Application - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 14. By Application - Global G-CSF Biosimilars Price (USD/Unit), 2017-2028
Figure 15. By Region - Global G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 16. By Region - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 17. By Country - North America G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 18. By Country - North America G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 19. US G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Canada G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 23. By Country - Europe G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 24. Germany G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. France G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Italy G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. Russia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 32. By Region - Asia G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 33. China G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Japan G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. India G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 39. By Country - South America G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 40. Brazil G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 44. Turkey G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 45. Israel G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 47. UAE G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 48. Global G-CSF Biosimilars Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production G-CSF Biosimilars by Region, 2021 VS 2028
Figure 50. G-CSF Biosimilars Industry Value Chain
Figure 51. Marketing Channels
Figure 1. G-CSF Biosimilars Segment by Type
Figure 2. G-CSF Biosimilars Segment by Application
Figure 3. Global G-CSF Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global G-CSF Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global G-CSF Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. G-CSF Biosimilars Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by G-CSF Biosimilars Revenue in 2021
Figure 9. By Type - Global G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 10. By Type - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Type - Global G-CSF Biosimilars Price (USD/Unit), 2017-2028
Figure 12. By Application - Global G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 13. By Application - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 14. By Application - Global G-CSF Biosimilars Price (USD/Unit), 2017-2028
Figure 15. By Region - Global G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 16. By Region - Global G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 17. By Country - North America G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 18. By Country - North America G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 19. US G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Canada G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 23. By Country - Europe G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 24. Germany G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. France G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Italy G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. Russia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 32. By Region - Asia G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 33. China G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Japan G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. India G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 39. By Country - South America G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 40. Brazil G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 44. Turkey G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 45. Israel G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 47. UAE G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 48. Global G-CSF Biosimilars Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production G-CSF Biosimilars by Region, 2021 VS 2028
Figure 50. G-CSF Biosimilars Industry Value Chain
Figure 51. Marketing Channels
